

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.42692598 |
| 2 | axon ensheathment (GO:0008366) | 7.04968897 |
| 3 | ensheathment of neurons (GO:0007272) | 7.04968897 |
| 4 | myelination (GO:0042552) | 6.96594054 |
| 5 | cholesterol biosynthetic process (GO:0006695) | 5.75698987 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.64332171 |
| 7 | myelin maintenance (GO:0043217) | 5.59067203 |
| 8 | creatine metabolic process (GO:0006600) | 5.33896354 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.25834861 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.25834861 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.05180919 |
| 12 | sterol biosynthetic process (GO:0016126) | 5.01922553 |
| 13 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.88219352 |
| 14 | amyloid precursor protein metabolic process (GO:0042982) | 4.87275703 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.76740820 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.76740820 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.76740820 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.76740820 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.76740820 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.76740820 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.63650304 |
| 22 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.60692947 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.51845590 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.48238831 |
| 25 | response to methylmercury (GO:0051597) | 4.43393373 |
| 26 | isoprenoid biosynthetic process (GO:0008299) | 4.27376104 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.21479388 |
| 28 | response to peptidoglycan (GO:0032494) | 4.17255436 |
| 29 | response to lipoprotein particle (GO:0055094) | 4.16919683 |
| 30 | virion attachment to host cell (GO:0019062) | 4.13427287 |
| 31 | adhesion of symbiont to host cell (GO:0044650) | 4.13427287 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 4.09026033 |
| 33 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.07992051 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 4.04731905 |
| 35 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.04458307 |
| 36 | detection of other organism (GO:0098543) | 4.04222551 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.00259070 |
| 38 | oligodendrocyte differentiation (GO:0048709) | 4.00015485 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.98922317 |
| 40 | glycerophospholipid catabolic process (GO:0046475) | 3.97187520 |
| 41 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.94885096 |
| 42 | regulation of collateral sprouting (GO:0048670) | 3.93990093 |
| 43 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.93446691 |
| 44 | amyloid precursor protein catabolic process (GO:0042987) | 3.91999601 |
| 45 | protein localization to endosome (GO:0036010) | 3.88611965 |
| 46 | cellular extravasation (GO:0045123) | 3.85941858 |
| 47 | astrocyte development (GO:0014002) | 3.83221149 |
| 48 | detection of bacterium (GO:0016045) | 3.82733847 |
| 49 | asymmetric protein localization (GO:0008105) | 3.81397703 |
| 50 | import into cell (GO:0098657) | 3.77434146 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.74241761 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 3.65642068 |
| 53 | regulation of lipoprotein metabolic process (GO:0050746) | 3.63069683 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.62506429 |
| 55 | magnesium ion transport (GO:0015693) | 3.62197703 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.62037960 |
| 57 | photoreceptor cell differentiation (GO:0046530) | 3.60589573 |
| 58 | eye photoreceptor cell differentiation (GO:0001754) | 3.60589573 |
| 59 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.60161821 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 3.58915737 |
| 61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.58457058 |
| 62 | nucleotide transmembrane transport (GO:1901679) | 3.58228845 |
| 63 | detection of external biotic stimulus (GO:0098581) | 3.58203602 |
| 64 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.49907771 |
| 65 | thioester biosynthetic process (GO:0035384) | 3.49274392 |
| 66 | acyl-CoA biosynthetic process (GO:0071616) | 3.49274392 |
| 67 | substantia nigra development (GO:0021762) | 3.48441457 |
| 68 | establishment of mitochondrion localization (GO:0051654) | 3.48092387 |
| 69 | negative regulation of protein localization to cell surface (GO:2000009) | 3.46438960 |
| 70 | response to host immune response (GO:0052572) | 3.46322570 |
| 71 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.46322570 |
| 72 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.44495057 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43937690 |
| 74 | protein palmitoylation (GO:0018345) | 3.43812222 |
| 75 | response to redox state (GO:0051775) | 3.42916128 |
| 76 | glycosylceramide metabolic process (GO:0006677) | 3.39012333 |
| 77 | very long-chain fatty acid metabolic process (GO:0000038) | 3.37249921 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 3.36962627 |
| 79 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.35429370 |
| 80 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.29512940 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29364300 |
| 82 | GPI anchor biosynthetic process (GO:0006506) | 3.29009245 |
| 83 | signal peptide processing (GO:0006465) | 3.27620731 |
| 84 | positive regulation of mast cell activation (GO:0033005) | 3.26996750 |
| 85 | negative thymic T cell selection (GO:0045060) | 3.26354773 |
| 86 | membrane raft organization (GO:0031579) | 3.26176535 |
| 87 | negative T cell selection (GO:0043383) | 3.24740358 |
| 88 | adhesion of symbiont to host (GO:0044406) | 3.24319340 |
| 89 | response to host (GO:0075136) | 3.23516179 |
| 90 | response to host defenses (GO:0052200) | 3.23516179 |
| 91 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23516179 |
| 92 | positive thymic T cell selection (GO:0045059) | 3.21761962 |
| 93 | neutrophil activation (GO:0042119) | 3.21603194 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 3.19680642 |
| 95 | membrane protein ectodomain proteolysis (GO:0006509) | 3.19205230 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 3.19040711 |
| 97 | response to interleukin-15 (GO:0070672) | 3.17137625 |
| 98 | apical protein localization (GO:0045176) | 3.16743351 |
| 99 | microglial cell activation (GO:0001774) | 3.14018514 |
| 100 | germinal center formation (GO:0002467) | 3.13077710 |
| 101 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.12675637 |
| 102 | type I interferon signaling pathway (GO:0060337) | 3.11779640 |
| 103 | cellular response to type I interferon (GO:0071357) | 3.11779640 |
| 104 | GPI anchor metabolic process (GO:0006505) | 3.11736579 |
| 105 | regulation of tolerance induction (GO:0002643) | 3.11295492 |
| 106 | granulocyte activation (GO:0036230) | 3.10662094 |
| 107 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.09593699 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 3.09293868 |
| 109 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08837945 |
| 110 | response to type I interferon (GO:0034340) | 3.08114450 |
| 111 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.07539263 |
| 112 | axon development (GO:0061564) | 3.07449646 |
| 113 | tissue regeneration (GO:0042246) | 3.06883703 |
| 114 | detection of biotic stimulus (GO:0009595) | 3.06770925 |
| 115 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.06103571 |
| 116 | tolerance induction (GO:0002507) | 3.04976158 |
| 117 | T cell migration (GO:0072678) | 3.04263362 |
| 118 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02459314 |
| 119 | B cell mediated immunity (GO:0019724) | 3.02417471 |
| 120 | heme transport (GO:0015886) | 3.01261778 |
| 121 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.00750663 |
| 122 | regulation of B cell differentiation (GO:0045577) | 2.97680685 |
| 123 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97570768 |
| 124 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.96682749 |
| 125 | macrophage activation (GO:0042116) | 2.96077700 |
| 126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92971280 |
| 127 | positive regulation of glial cell differentiation (GO:0045687) | 2.92866529 |
| 128 | myelination in peripheral nervous system (GO:0022011) | 2.92773360 |
| 129 | peripheral nervous system axon ensheathment (GO:0032292) | 2.92773360 |
| 130 | T cell selection (GO:0045058) | 2.92661157 |
| 131 | NIK/NF-kappaB signaling (GO:0038061) | 2.92640518 |
| 132 | localization within membrane (GO:0051668) | 2.92436544 |
| 133 | response to muramyl dipeptide (GO:0032495) | 2.92185312 |
| 134 | negative regulation of glucose import (GO:0046325) | 2.89809732 |
| 135 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.89765269 |
| 136 | myeloid dendritic cell differentiation (GO:0043011) | 2.88820061 |
| 137 | response to lead ion (GO:0010288) | 2.88267434 |
| 138 | membrane tubulation (GO:0097320) | 2.87940673 |
| 139 | cellular response to interleukin-15 (GO:0071350) | 2.86252070 |
| 140 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.85694040 |
| 141 | positive regulation of gliogenesis (GO:0014015) | 2.85401882 |
| 142 | positive T cell selection (GO:0043368) | 2.85014606 |
| 143 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84351687 |
| 144 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81691582 |
| 145 | respiratory burst (GO:0045730) | 2.81309476 |
| 146 | neutrophil activation involved in immune response (GO:0002283) | 2.80244952 |
| 147 | positive regulation of actin filament depolymerization (GO:0030836) | 2.79670193 |
| 148 | activated T cell proliferation (GO:0050798) | 2.79551532 |
| 149 | peptidyl-cysteine modification (GO:0018198) | 2.79343720 |
| 150 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79183646 |
| 151 | regulation of regulatory T cell differentiation (GO:0045589) | 2.78335928 |
| 152 | defense response to protozoan (GO:0042832) | 2.78255221 |
| 153 | positive regulation of type 2 immune response (GO:0002830) | 2.78243273 |
| 154 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78200358 |
| 155 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78200358 |
| 156 | L-phenylalanine catabolic process (GO:0006559) | 2.77707209 |
| 157 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.77707209 |
| 158 | regulation of mast cell activation (GO:0033003) | 2.77602806 |
| 159 | myeloid dendritic cell activation (GO:0001773) | 2.77543742 |
| 160 | cholesterol metabolic process (GO:0008203) | 2.75740427 |
| 161 | leukocyte aggregation (GO:0070486) | 2.74879278 |
| 162 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74633135 |
| 163 | regulation of leukocyte degranulation (GO:0043300) | 2.72504011 |
| 164 | positive regulation of B cell mediated immunity (GO:0002714) | 2.71920245 |
| 165 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.71920245 |
| 166 | positive regulation of interleukin-17 production (GO:0032740) | 2.70718971 |
| 167 | thymic T cell selection (GO:0045061) | 2.70609974 |
| 168 | T-helper 1 type immune response (GO:0042088) | 2.69316980 |
| 169 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.68964073 |
| 170 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.68892106 |
| 171 | positive regulation of tolerance induction (GO:0002645) | 2.67006394 |
| 172 | * negative regulation of neurotransmitter secretion (GO:0046929) | 2.66779865 |
| 173 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66513378 |
| 174 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.65717551 |
| 175 | regulation of necroptotic process (GO:0060544) | 2.64511735 |
| 176 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.63254268 |
| 177 | alcohol biosynthetic process (GO:0046165) | 2.60996570 |
| 178 | cortical actin cytoskeleton organization (GO:0030866) | 2.59556235 |
| 179 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57959855 |
| 180 | negative regulation of interleukin-10 production (GO:0032693) | 2.55870003 |
| 181 | Golgi to endosome transport (GO:0006895) | 2.52422063 |
| 182 | negative regulation of acute inflammatory response (GO:0002674) | 2.52115471 |
| 183 | organ growth (GO:0035265) | 2.51596745 |
| 184 | glial cell development (GO:0021782) | 2.50886420 |
| 185 | negative regulation of JUN kinase activity (GO:0043508) | 2.49116774 |
| 186 | nucleotide transport (GO:0006862) | 2.48846362 |
| 187 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.48410467 |
| 188 | L-amino acid import (GO:0043092) | 2.48300465 |
| 189 | histone H2B ubiquitination (GO:0033523) | 2.48109957 |
| 190 | Leydig cell differentiation (GO:0033327) | 2.47862875 |
| 191 | sterol metabolic process (GO:0016125) | 2.47216359 |
| 192 | * negative regulation of neurotransmitter transport (GO:0051589) | 2.46510720 |
| 193 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.46291531 |
| 194 | ear development (GO:0043583) | 2.45517880 |
| 195 | ER overload response (GO:0006983) | 2.44084689 |
| 196 | axon ensheathment in central nervous system (GO:0032291) | 10.5020090 |
| 197 | central nervous system myelination (GO:0022010) | 10.5020090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.82234265 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.11874533 |
| 3 | * SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.96038144 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.38855112 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.03235632 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.83618354 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77439982 |
| 8 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.75068296 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.73583750 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.62173234 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60511196 |
| 12 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.59063785 |
| 13 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.48546236 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36908847 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22479831 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16673756 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.16173382 |
| 18 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13937946 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.12790736 |
| 20 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.11726360 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01732488 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98754138 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97244873 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96237939 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.92085713 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91641950 |
| 27 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.89630314 |
| 28 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88777408 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87962918 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.85812855 |
| 31 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85675360 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69378889 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68527528 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67636634 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65981324 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.62872396 |
| 37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.61623802 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60710722 |
| 39 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56125161 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53767269 |
| 41 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52240530 |
| 42 | * MYB_26560356_Chip-Seq_TH2_Human | 1.51561014 |
| 43 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50298182 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49996972 |
| 45 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49540141 |
| 46 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48181044 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47677734 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44558520 |
| 49 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.44077673 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42870727 |
| 51 | * MAF_26560356_Chip-Seq_TH2_Human | 1.42402593 |
| 52 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41919009 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41364138 |
| 54 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.41074424 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40667066 |
| 56 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38994418 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38879666 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36490357 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35908777 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35908777 |
| 61 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.34567710 |
| 62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33571386 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33563591 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32941763 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32765040 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31961193 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31340596 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31165681 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30843705 |
| 70 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29994009 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29581024 |
| 72 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.29036653 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26914444 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26808724 |
| 75 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26670648 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24976984 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22150511 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21931974 |
| 79 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19481662 |
| 80 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17334087 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15253450 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14572805 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14449297 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13594431 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13542267 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12886317 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12700354 |
| 88 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12144734 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11148300 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09334904 |
| 91 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.07333016 |
| 92 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.07151402 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07112496 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06669704 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06383173 |
| 96 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06128848 |
| 97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05842369 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04619121 |
| 99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03444338 |
| 100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03315070 |
| 101 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02608338 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02511374 |
| 103 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02224756 |
| 104 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02210607 |
| 105 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01813905 |
| 106 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.01175564 |
| 107 | * MYB_26560356_Chip-Seq_TH1_Human | 1.01047594 |
| 108 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00696107 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99721549 |
| 110 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99686086 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99292868 |
| 112 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97762749 |
| 113 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97523305 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97398149 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97247497 |
| 116 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96664630 |
| 117 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96586694 |
| 118 | * MAF_26560356_Chip-Seq_TH1_Human | 0.94830970 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94540889 |
| 120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93985655 |
| 121 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93881414 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93389310 |
| 123 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93388232 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92491319 |
| 125 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.91674862 |
| 126 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91398895 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91396332 |
| 128 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90979661 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90674068 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90123876 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89948042 |
| 132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89248592 |
| 133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89209375 |
| 134 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88926486 |
| 135 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88776930 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88764901 |
| 137 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88736779 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88682461 |
| 139 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88522635 |
| 140 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86013432 |
| 141 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.85391565 |
| 142 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.84946320 |
| 143 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84508311 |
| 144 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.84283813 |
| 145 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84252128 |
| 146 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82330249 |
| 147 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.81633044 |
| 148 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.81389741 |
| 149 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77302338 |
| 150 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.73965995 |
| 151 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.73282933 |
| 152 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72485491 |
| 153 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71296207 |
| 154 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.69306181 |
| 155 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.69227446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.98530217 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.63149811 |
| 3 | MP0003690_abnormal_glial_cell | 3.57354736 |
| 4 | MP0006082_CNS_inflammation | 2.48337697 |
| 5 | MP0010678_abnormal_skin_adnexa | 2.47194717 |
| 6 | MP0005451_abnormal_body_composition | 2.35601113 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.33559694 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.28078321 |
| 9 | MP0003329_amyloid_beta_deposits | 2.27852229 |
| 10 | MP0000383_abnormal_hair_follicle | 2.22049374 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 2.15320244 |
| 12 | MP0004147_increased_porphyrin_level | 2.10877545 |
| 13 | MP0001661_extended_life_span | 2.06222250 |
| 14 | MP0003828_pulmonary_edema | 2.01094837 |
| 15 | MP0003724_increased_susceptibility_to | 1.99018961 |
| 16 | MP0001790_abnormal_immune_system | 1.96490594 |
| 17 | MP0005387_immune_system_phenotype | 1.96490594 |
| 18 | MP0005671_abnormal_response_to | 1.94599992 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 1.92958305 |
| 20 | MP0003634_abnormal_glial_cell | 1.91232575 |
| 21 | MP0000604_amyloidosis | 1.90775150 |
| 22 | MP0004885_abnormal_endolymph | 1.87888006 |
| 23 | MP0009840_abnormal_foam_cell | 1.87376245 |
| 24 | MP0003195_calcinosis | 1.87371221 |
| 25 | MP0004381_abnormal_hair_follicle | 1.85654401 |
| 26 | MP0001851_eye_inflammation | 1.84159255 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.83283328 |
| 28 | MP0005409_darkened_coat_color | 1.77453734 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.76873263 |
| 30 | MP0001905_abnormal_dopamine_level | 1.74583682 |
| 31 | MP0004510_myositis | 1.71695720 |
| 32 | MP0000685_abnormal_immune_system | 1.71548365 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.68299678 |
| 34 | MP0003303_peritoneal_inflammation | 1.67179019 |
| 35 | MP0004742_abnormal_vestibular_system | 1.65609019 |
| 36 | MP0008260_abnormal_autophagy | 1.62366038 |
| 37 | MP0001485_abnormal_pinna_reflex | 1.59586307 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.57755684 |
| 39 | MP0002933_joint_inflammation | 1.56543454 |
| 40 | MP0005025_abnormal_response_to | 1.54814048 |
| 41 | MP0001800_abnormal_humoral_immune | 1.54237864 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.53923671 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.52304587 |
| 44 | MP0005408_hypopigmentation | 1.51903912 |
| 45 | MP0008004_abnormal_stomach_pH | 1.51007955 |
| 46 | * MP0002723_abnormal_immune_serum | 1.50896314 |
| 47 | * MP0002419_abnormal_innate_immunity | 1.49223163 |
| 48 | MP0004134_abnormal_chest_morphology | 1.48886192 |
| 49 | MP0000343_altered_response_to | 1.46187467 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.43402496 |
| 51 | MP0000462_abnormal_digestive_system | 1.43226813 |
| 52 | MP0003136_yellow_coat_color | 1.40550929 |
| 53 | MP0001853_heart_inflammation | 1.38385719 |
| 54 | MP0003866_abnormal_defecation | 1.34214800 |
| 55 | * MP0002420_abnormal_adaptive_immunity | 1.34119410 |
| 56 | * MP0002452_abnormal_antigen_presenting | 1.33480511 |
| 57 | MP0003632_abnormal_nervous_system | 1.32716313 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.31972145 |
| 59 | MP0000858_altered_metastatic_potential | 1.31169224 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.31018248 |
| 61 | MP0005310_abnormal_salivary_gland | 1.30581553 |
| 62 | * MP0001819_abnormal_immune_cell | 1.30087979 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.27346691 |
| 64 | MP0001529_abnormal_vocalization | 1.25862701 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.23819939 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.23664641 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.23664641 |
| 68 | MP0005171_absent_coat_pigmentation | 1.22726231 |
| 69 | MP0005166_decreased_susceptibility_to | 1.22210342 |
| 70 | MP0009785_altered_susceptibility_to | 1.22109661 |
| 71 | MP0009764_decreased_sensitivity_to | 1.20750687 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.18715432 |
| 73 | MP0000747_muscle_weakness | 1.18543646 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 1.18443908 |
| 75 | MP0002229_neurodegeneration | 1.17849162 |
| 76 | MP0009278_abnormal_bone_marrow | 1.17444384 |
| 77 | MP0000647_abnormal_sebaceous_gland | 1.11159594 |
| 78 | * MP0000716_abnormal_immune_system | 1.10593266 |
| 79 | MP0002006_tumorigenesis | 1.09112648 |
| 80 | MP0003448_altered_tumor_morphology | 1.07159269 |
| 81 | MP0003091_abnormal_cell_migration | 1.06471544 |
| 82 | MP0003045_fibrosis | 1.03974450 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.02751692 |
| 84 | MP0004883_abnormal_blood_vessel | 1.01394014 |
| 85 | MP0004142_abnormal_muscle_tone | 1.00965441 |
| 86 | MP0002132_abnormal_respiratory_system | 0.99702697 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.99105858 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.95275390 |
| 89 | MP0001346_abnormal_lacrimal_gland | 0.95264844 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94214163 |
| 91 | MP0002295_abnormal_pulmonary_circulatio | 0.93775972 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.93504345 |
| 93 | MP0005164_abnormal_response_to | 0.91707262 |
| 94 | MP0002405_respiratory_system_inflammati | 0.90535885 |
| 95 | MP0004043_abnormal_pH_regulation | 0.87704025 |
| 96 | MP0000249_abnormal_blood_vessel | 0.87672220 |
| 97 | MP0003186_abnormal_redox_activity | 0.86479722 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.85864919 |
| 99 | MP0004270_analgesia | 0.84233564 |
| 100 | * MP0002398_abnormal_bone_marrow | 0.84115397 |
| 101 | MP0003075_altered_response_to | 0.83986888 |
| 102 | MP0008469_abnormal_protein_level | 0.83266417 |
| 103 | MP0004947_skin_inflammation | 0.83029173 |
| 104 | MP0003763_abnormal_thymus_physiology | 0.82946379 |
| 105 | MP0005083_abnormal_biliary_tract | 0.82495988 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.82480679 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.81189131 |
| 108 | MP0000377_abnormal_hair_follicle | 0.81165349 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.80567310 |
| 110 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80466193 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.80035620 |
| 112 | MP0003436_decreased_susceptibility_to | 0.79998856 |
| 113 | MP0000689_abnormal_spleen_morphology | 0.79842564 |
| 114 | * MP0002429_abnormal_blood_cell | 0.79710289 |
| 115 | MP0008874_decreased_physiological_sensi | 0.79293904 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.79048296 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76929968 |
| 118 | MP0001958_emphysema | 0.76341881 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.75934713 |
| 120 | MP0004130_abnormal_muscle_cell | 0.75609494 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.74657761 |
| 122 | MP0002009_preneoplasia | 0.73874786 |
| 123 | MP0001663_abnormal_digestive_system | 0.73826715 |
| 124 | MP0001666_abnormal_nutrient_absorption | 0.73027716 |
| 125 | MP0002396_abnormal_hematopoietic_system | 0.72536037 |
| 126 | MP0003191_abnormal_cellular_cholesterol | 0.71934659 |
| 127 | MP0003795_abnormal_bone_structure | 0.71754648 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.70982435 |
| 129 | MP0004084_abnormal_cardiac_muscle | 0.70834320 |
| 130 | MP0009115_abnormal_fat_cell | 0.68292229 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.68226679 |
| 132 | MP0005410_abnormal_fertilization | 0.68124836 |
| 133 | MP0008057_abnormal_DNA_replication | 0.67502365 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.66315630 |
| 135 | MP0002722_abnormal_immune_system | 0.66054201 |
| 136 | MP0005381_digestive/alimentary_phenotyp | 0.66019595 |
| 137 | MP0001873_stomach_inflammation | 0.65720507 |
| 138 | MP0009763_increased_sensitivity_to | 0.65042248 |
| 139 | MP0005390_skeleton_phenotype | 0.64833420 |
| 140 | MP0004036_abnormal_muscle_relaxation | 0.61112766 |
| 141 | MP0002277_abnormal_respiratory_mucosa | 0.60250876 |
| 142 | MP0004484_altered_response_of | 0.59331514 |
| 143 | MP0002332_abnormal_exercise_endurance | 0.58867847 |
| 144 | MP0000609_abnormal_liver_physiology | 0.58544574 |
| 145 | MP0000490_abnormal_crypts_of | 0.58352561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.35858643 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.35858643 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.86993389 |
| 4 | Sensory axonal neuropathy (HP:0003390) | 5.27443157 |
| 5 | Parakeratosis (HP:0001036) | 4.93948493 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 4.19552511 |
| 7 | Cerebral inclusion bodies (HP:0100314) | 4.04151614 |
| 8 | Spontaneous hematomas (HP:0007420) | 4.02638754 |
| 9 | Peripheral hypomyelination (HP:0007182) | 4.00203078 |
| 10 | Myositis (HP:0100614) | 3.78069875 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.65183176 |
| 12 | Onion bulb formation (HP:0003383) | 3.61695754 |
| 13 | Orchitis (HP:0100796) | 3.60903591 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.52400307 |
| 15 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.50560724 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.49789286 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.44982950 |
| 18 | Optic neuritis (HP:0100653) | 3.44982950 |
| 19 | Meningitis (HP:0001287) | 3.44951444 |
| 20 | Prolonged bleeding time (HP:0003010) | 3.37176811 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.36082102 |
| 22 | Cerebral hypomyelination (HP:0006808) | 3.36024648 |
| 23 | Vasculitis (HP:0002633) | 3.34015082 |
| 24 | Termporal pattern (HP:0011008) | 3.26396272 |
| 25 | Insidious onset (HP:0003587) | 3.26396272 |
| 26 | Premature skin wrinkling (HP:0100678) | 3.24497578 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21357958 |
| 28 | Obstructive lung disease (HP:0006536) | 3.21357958 |
| 29 | Hepatosplenomegaly (HP:0001433) | 3.20676668 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.18565261 |
| 31 | Abnormal auditory evoked potentials (HP:0006958) | 3.16928124 |
| 32 | Spastic paraparesis (HP:0002313) | 3.15517962 |
| 33 | Chronic otitis media (HP:0000389) | 3.11122851 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07806450 |
| 35 | Slow saccadic eye movements (HP:0000514) | 3.04943207 |
| 36 | Cerebral hemorrhage (HP:0001342) | 3.01985580 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 3.01536677 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.01536677 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00227474 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00227474 |
| 41 | Autoamputation (HP:0001218) | 2.99342147 |
| 42 | Epistaxis (HP:0000421) | 2.99205488 |
| 43 | Petechiae (HP:0000967) | 2.95557312 |
| 44 | Stridor (HP:0010307) | 2.91847922 |
| 45 | Spastic gait (HP:0002064) | 2.91043450 |
| 46 | Intention tremor (HP:0002080) | 2.89855996 |
| 47 | Gingivitis (HP:0000230) | 2.85850560 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.85303501 |
| 49 | Encephalitis (HP:0002383) | 2.85171188 |
| 50 | Urticaria (HP:0001025) | 2.83859911 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.83180048 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.83180048 |
| 53 | Increased IgE level (HP:0003212) | 2.83044478 |
| 54 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.80213170 |
| 55 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.78309897 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.71809149 |
| 57 | Akinesia (HP:0002304) | 2.70446620 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.70320048 |
| 59 | Anteriorly placed anus (HP:0001545) | 2.69838248 |
| 60 | Chest pain (HP:0100749) | 2.62248196 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.59763285 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.59037826 |
| 63 | Hemoptysis (HP:0002105) | 2.57257482 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.55611291 |
| 65 | Abnormality of T cells (HP:0002843) | 2.52983264 |
| 66 | Osteomyelitis (HP:0002754) | 2.50479939 |
| 67 | Increased IgM level (HP:0003496) | 2.50366692 |
| 68 | Axonal loss (HP:0003447) | 2.50348401 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.49168651 |
| 70 | T lymphocytopenia (HP:0005403) | 2.46094013 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.45599911 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.43289879 |
| 73 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.40046719 |
| 74 | Thickened helices (HP:0000391) | 2.39804820 |
| 75 | Recurrent skin infections (HP:0001581) | 2.38055578 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.37887425 |
| 77 | Arterial thrombosis (HP:0004420) | 2.37279086 |
| 78 | Leukocytosis (HP:0001974) | 2.35936216 |
| 79 | Stomatitis (HP:0010280) | 2.35816032 |
| 80 | Retinal dysplasia (HP:0007973) | 2.35533781 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.34804076 |
| 82 | Colitis (HP:0002583) | 2.34046429 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31573668 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 2.31573668 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.30211834 |
| 86 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.28934700 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 2.28064185 |
| 88 | Leukodystrophy (HP:0002415) | 2.26836311 |
| 89 | Lymphopenia (HP:0001888) | 2.26587030 |
| 90 | Alacrima (HP:0000522) | 2.24981778 |
| 91 | Granulocytopenia (HP:0001913) | 2.24786762 |
| 92 | Abnormal platelet volume (HP:0011876) | 2.24653446 |
| 93 | Scanning speech (HP:0002168) | 2.24222318 |
| 94 | Hyperlipoproteinemia (HP:0010980) | 2.23174371 |
| 95 | Recurrent bronchitis (HP:0002837) | 2.22980544 |
| 96 | Pustule (HP:0200039) | 2.21833552 |
| 97 | Dysmetria (HP:0001310) | 2.20088528 |
| 98 | Purpura (HP:0000979) | 2.18840200 |
| 99 | Clumsiness (HP:0002312) | 2.18545728 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 2.17146515 |
| 101 | Paraparesis (HP:0002385) | 2.16553903 |
| 102 | Papilledema (HP:0001085) | 2.15711158 |
| 103 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15538031 |
| 104 | Chronic diarrhea (HP:0002028) | 2.15206288 |
| 105 | Fatigue (HP:0012378) | 2.15121586 |
| 106 | Polycythemia (HP:0001901) | 2.13903856 |
| 107 | Peripheral demyelination (HP:0011096) | 2.11778804 |
| 108 | Autoimmune thrombocytopenia (HP:0001973) | 2.10920396 |
| 109 | Prolonged neonatal jaundice (HP:0006579) | 2.10856245 |
| 110 | Episodic fever (HP:0001954) | 2.07452621 |
| 111 | Intrahepatic cholestasis (HP:0001406) | 2.06931081 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 2.06103150 |
| 113 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05535636 |
| 114 | CNS hypomyelination (HP:0003429) | 2.03501292 |
| 115 | Patchy hypopigmentation of hair (HP:0011365) | 2.02930728 |
| 116 | Hypoplastic pelvis (HP:0008839) | 2.02864018 |
| 117 | Anorexia (HP:0002039) | 2.02846238 |
| 118 | Erythroderma (HP:0001019) | 2.02602464 |
| 119 | Progressive neurologic deterioration (HP:0002344) | 1.97914960 |
| 120 | Joint swelling (HP:0001386) | 1.97676411 |
| 121 | Verrucae (HP:0200043) | 1.97230770 |
| 122 | Papilloma (HP:0012740) | 1.97230770 |
| 123 | Gangrene (HP:0100758) | 1.96633749 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 1.96370421 |
| 125 | Hematochezia (HP:0002573) | 1.94581981 |
| 126 | Skin ulcer (HP:0200042) | 1.94181071 |
| 127 | Eosinophilia (HP:0001880) | 1.92895061 |
| 128 | Barrel-shaped chest (HP:0001552) | 1.92639738 |
| 129 | Emphysema (HP:0002097) | 1.92370002 |
| 130 | Vacuolated lymphocytes (HP:0001922) | 1.91852727 |
| 131 | Recurrent abscess formation (HP:0002722) | 1.91019218 |
| 132 | Pulmonary embolism (HP:0002204) | 1.89759462 |
| 133 | Hypokalemic alkalosis (HP:0001949) | 1.88913802 |
| 134 | Loss of speech (HP:0002371) | 1.88662609 |
| 135 | Recurrent bacterial skin infections (HP:0005406) | 1.88506158 |
| 136 | Spastic tetraparesis (HP:0001285) | 1.87416359 |
| 137 | Cellulitis (HP:0100658) | 1.87269289 |
| 138 | Amyloidosis (HP:0011034) | 1.87047938 |
| 139 | Sepsis (HP:0100806) | 1.86981974 |
| 140 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.86724016 |
| 141 | White forelock (HP:0002211) | 1.85964016 |
| 142 | Microcytic anemia (HP:0001935) | 1.85786118 |
| 143 | Abnormality of the endocardium (HP:0004306) | 1.84976441 |
| 144 | Disinhibition (HP:0000734) | 1.84886705 |
| 145 | Impaired platelet aggregation (HP:0003540) | 1.84826125 |
| 146 | Abnormal platelet function (HP:0011869) | 1.84826125 |
| 147 | Increased circulating renin level (HP:0000848) | 1.84532921 |
| 148 | Abnormality of the peritoneum (HP:0002585) | 1.84295537 |
| 149 | Polyneuropathy (HP:0001271) | 1.83980160 |
| 150 | Mucosal telangiectasiae (HP:0100579) | 1.82823562 |
| 151 | Increased serum ferritin (HP:0003281) | 1.82131729 |
| 152 | Postnatal microcephaly (HP:0005484) | 1.79920199 |
| 153 | Steatorrhea (HP:0002570) | 1.79730910 |
| 154 | Recurrent viral infections (HP:0004429) | 1.78201173 |
| 155 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77202614 |
| 156 | Muscle fiber splitting (HP:0003555) | 1.76666853 |
| 157 | 3-Methylglutaconic aciduria (HP:0003535) | 1.76506194 |
| 158 | Small epiphyses (HP:0010585) | 1.76062679 |
| 159 | Infantile muscular hypotonia (HP:0008947) | 1.75914924 |
| 160 | Eczematoid dermatitis (HP:0000976) | 1.74532075 |
| 161 | Paralysis (HP:0003470) | 1.74528439 |
| 162 | Dysostosis multiplex (HP:0000943) | 1.73845216 |
| 163 | Hypomagnesemia (HP:0002917) | 1.73102181 |
| 164 | Morphological abnormality of the inner ear (HP:0011390) | 1.72284007 |
| 165 | Metabolic alkalosis (HP:0200114) | 1.70114187 |
| 166 | Cupped ear (HP:0000378) | 1.68440618 |
| 167 | Seborrheic dermatitis (HP:0001051) | 1.67522398 |
| 168 | Gingival bleeding (HP:0000225) | 1.67483707 |
| 169 | Decreased lacrimation (HP:0000633) | 1.66738581 |
| 170 | Cerebellar dysplasia (HP:0007033) | 1.66098520 |
| 171 | Xanthomatosis (HP:0000991) | 1.65584591 |
| 172 | Urinary incontinence (HP:0000020) | 1.65563375 |
| 173 | Ileus (HP:0002595) | 1.64326997 |
| 174 | Restrictive lung disease (HP:0002091) | 1.63112191 |
| 175 | Anomalous pulmonary venous return (HP:0010772) | 1.63089915 |
| 176 | Gowers sign (HP:0003391) | 1.62630605 |
| 177 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.61954085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.33807676 |
| 2 | EPHB1 | 4.70149307 |
| 3 | RIPK4 | 4.66419919 |
| 4 | OXSR1 | 4.13068554 |
| 5 | PRPF4B | 3.14170871 |
| 6 | PBK | 2.69528953 |
| 7 | MAPKAPK5 | 2.39399515 |
| 8 | MAP2K3 | 2.38070362 |
| 9 | MET | 2.29739461 |
| 10 | CDK19 | 2.28182966 |
| 11 | WNK4 | 2.27164090 |
| 12 | ERN1 | 2.22627592 |
| 13 | MST4 | 2.18765166 |
| 14 | PKN1 | 2.09703606 |
| 15 | BCR | 2.02316499 |
| 16 | TNIK | 2.01797569 |
| 17 | FGFR2 | 1.97229874 |
| 18 | CLK1 | 1.95236265 |
| 19 | MAP4K1 | 1.82199053 |
| 20 | SYK | 1.74956840 |
| 21 | CSNK1A1L | 1.70568707 |
| 22 | WNK1 | 1.68940261 |
| 23 | CSNK1G3 | 1.68703274 |
| 24 | TESK2 | 1.67391400 |
| 25 | FGR | 1.63726819 |
| 26 | STK10 | 1.60046409 |
| 27 | BMPR2 | 1.56387111 |
| 28 | LIMK1 | 1.53758701 |
| 29 | MAP3K3 | 1.52857104 |
| 30 | BLK | 1.50400018 |
| 31 | CSNK1G1 | 1.46310388 |
| 32 | ITK | 1.36973280 |
| 33 | NEK9 | 1.36372236 |
| 34 | TAOK1 | 1.35804010 |
| 35 | TAOK3 | 1.33216505 |
| 36 | KSR2 | 1.33108456 |
| 37 | SIK3 | 1.33092643 |
| 38 | TAOK2 | 1.31553601 |
| 39 | MAP3K1 | 1.28101812 |
| 40 | IRAK4 | 1.27944302 |
| 41 | PRKCQ | 1.27793296 |
| 42 | JAK2 | 1.27612449 |
| 43 | FGFR3 | 1.23582191 |
| 44 | GRK6 | 1.23012832 |
| 45 | ROCK2 | 1.19031143 |
| 46 | MATK | 1.18686425 |
| 47 | CSF1R | 1.17439664 |
| 48 | ICK | 1.17013588 |
| 49 | MAP3K11 | 1.16032944 |
| 50 | CSK | 1.13518644 |
| 51 | UHMK1 | 1.13099595 |
| 52 | CSNK1G2 | 1.03246952 |
| 53 | TGFBR2 | 1.01230284 |
| 54 | MAPK12 | 0.98032367 |
| 55 | YES1 | 0.95671870 |
| 56 | TXK | 0.95480177 |
| 57 | IRAK1 | 0.94991169 |
| 58 | TNK2 | 0.92471184 |
| 59 | NEK6 | 0.91378244 |
| 60 | MAPK15 | 0.91156067 |
| 61 | CDC42BPA | 0.89700984 |
| 62 | MAP3K5 | 0.89271697 |
| 63 | MARK3 | 0.88206960 |
| 64 | NTRK1 | 0.87588484 |
| 65 | CAMK2B | 0.86960078 |
| 66 | CAMKK2 | 0.85971144 |
| 67 | KIT | 0.84875741 |
| 68 | IRAK3 | 0.83207560 |
| 69 | LCK | 0.83092953 |
| 70 | MAP3K13 | 0.82165372 |
| 71 | RPS6KA5 | 0.81942815 |
| 72 | LRRK2 | 0.81544018 |
| 73 | STK24 | 0.79591932 |
| 74 | CAMK2D | 0.70885004 |
| 75 | PRKD1 | 0.70482838 |
| 76 | MAP3K14 | 0.70239354 |
| 77 | NME2 | 0.69917636 |
| 78 | IRAK2 | 0.69598450 |
| 79 | MAP3K6 | 0.68445829 |
| 80 | MAPK7 | 0.68192144 |
| 81 | DMPK | 0.67940609 |
| 82 | NLK | 0.67903413 |
| 83 | SGK3 | 0.67316205 |
| 84 | TRPM7 | 0.65534732 |
| 85 | KDR | 0.64988666 |
| 86 | HIPK2 | 0.64811650 |
| 87 | NUAK1 | 0.63813802 |
| 88 | IKBKE | 0.61515963 |
| 89 | MAP3K2 | 0.61481149 |
| 90 | SCYL2 | 0.59538795 |
| 91 | TEC | 0.59500318 |
| 92 | GRK7 | 0.58376069 |
| 93 | MELK | 0.57719006 |
| 94 | TBK1 | 0.57111263 |
| 95 | RAF1 | 0.56588413 |
| 96 | BTK | 0.56580313 |
| 97 | SGK2 | 0.56457520 |
| 98 | JAK3 | 0.56330470 |
| 99 | TRIB3 | 0.56172039 |
| 100 | FYN | 0.55951810 |
| 101 | PNCK | 0.54950600 |
| 102 | GSK3A | 0.54802344 |
| 103 | PIM1 | 0.54009264 |
| 104 | PDPK1 | 0.52870114 |
| 105 | CAMK2G | 0.52064888 |
| 106 | CDK6 | 0.52010753 |
| 107 | STK4 | 0.51717102 |
| 108 | TIE1 | 0.51215982 |
| 109 | DYRK2 | 0.51011982 |
| 110 | TYK2 | 0.50908248 |
| 111 | MAP2K2 | 0.50004141 |
| 112 | PDGFRB | 0.49908376 |
| 113 | ERBB4 | 0.48783440 |
| 114 | LYN | 0.47374104 |
| 115 | FES | 0.46516636 |
| 116 | ZAP70 | 0.45876085 |
| 117 | ABL1 | 0.45875567 |
| 118 | CDK14 | 0.44864370 |
| 119 | TTN | 0.44852673 |
| 120 | CAMKK1 | 0.43945117 |
| 121 | ARAF | 0.43944553 |
| 122 | MARK2 | 0.43908087 |
| 123 | PAK6 | 0.43430649 |
| 124 | RPS6KC1 | 0.43158973 |
| 125 | RPS6KL1 | 0.43158973 |
| 126 | BMPR1B | 0.42377800 |
| 127 | CDK12 | 0.42096927 |
| 128 | MAPK11 | 0.42093110 |
| 129 | TYRO3 | 0.41594423 |
| 130 | MYLK | 0.40826785 |
| 131 | EIF2AK3 | 0.40399080 |
| 132 | IKBKB | 0.40216057 |
| 133 | EPHA3 | 0.40154664 |
| 134 | RIPK1 | 0.40138521 |
| 135 | MAPKAPK2 | 0.39991723 |
| 136 | PAK3 | 0.39755296 |
| 137 | INSR | 0.39387707 |
| 138 | MKNK1 | 0.38863149 |
| 139 | PRKD2 | 0.38514252 |
| 140 | MAP3K8 | 0.38491744 |
| 141 | PDK1 | 0.37461642 |
| 142 | PIK3CG | 0.36287040 |
| 143 | RET | 0.36038072 |
| 144 | CDK4 | 0.35449012 |
| 145 | MAPK4 | 0.35406702 |
| 146 | BCKDK | 0.35391862 |
| 147 | SIK1 | 0.35387843 |
| 148 | MOS | 0.33943635 |
| 149 | JAK1 | 0.33881440 |
| 150 | FGFR4 | 0.33028854 |
| 151 | HCK | 0.32334834 |
| 152 | SGK223 | 0.31248442 |
| 153 | SGK494 | 0.31248442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.67811510 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.19884298 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.37159655 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.25498107 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.16456602 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.13703755 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.65221416 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.36174700 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.15839028 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08094761 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.01466827 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.01434957 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.01098992 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80225763 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79890381 |
| 16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.69837851 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67290775 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62815213 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55755759 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.52560650 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52068127 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49357635 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49234634 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40376261 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38728744 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34941527 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32416280 |
| 28 | * Platelet activation_Homo sapiens_hsa04611 | 1.29000414 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26569305 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25263489 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24424351 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23776643 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.23660855 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23098750 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.20554436 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19969360 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.19054828 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.18472636 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18385301 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16021318 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15442953 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.14011936 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11648472 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11468793 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.07502408 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06414831 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06176029 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04169335 |
| 49 | Asthma_Homo sapiens_hsa05310 | 1.04105540 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96773572 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95336666 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94944990 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94179690 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93889405 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93633679 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.93259178 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92173879 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91677154 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91149036 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.90431627 |
| 61 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90059516 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88541479 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.86466858 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85842664 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85324302 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82897410 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82304727 |
| 68 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81982938 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80982382 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80872864 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.78917868 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78320341 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75750232 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.74531808 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.72000938 |
| 76 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71928596 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69495739 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68286669 |
| 79 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67965156 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67600287 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.66193257 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.65669983 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63987542 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63360471 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63164869 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62129504 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61675239 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.61603139 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61566323 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61098473 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60326026 |
| 92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59989137 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59974139 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59474185 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59161676 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58179767 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58102059 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57863528 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56420550 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55521698 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.54098178 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52877170 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52822079 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52474727 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52144133 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50973587 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50401304 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49373496 |
| 109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49350939 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.49205354 |
| 111 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49159051 |
| 112 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46242111 |
| 113 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46217199 |
| 114 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46200974 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46181324 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45964468 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45901176 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44812611 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44294859 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43568521 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42686011 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41814832 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.41301023 |
| 124 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41239459 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.41146565 |
| 126 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40779319 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39957069 |
| 128 | * Long-term potentiation_Homo sapiens_hsa04720 | 0.39482039 |
| 129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39445408 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39078213 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38906857 |
| 132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38870636 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38848601 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38625132 |
| 135 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38517843 |
| 136 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38015869 |
| 137 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37896701 |
| 138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37104594 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36766887 |
| 140 | Measles_Homo sapiens_hsa05162 | 0.36587787 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36581661 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36011141 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35959482 |
| 144 | Glioma_Homo sapiens_hsa05214 | 0.34191408 |
| 145 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33179051 |
| 146 | Prostate cancer_Homo sapiens_hsa05215 | 0.32466787 |
| 147 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.32077172 |
| 148 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.32061098 |
| 149 | ABC transporters_Homo sapiens_hsa02010 | 0.31749658 |
| 150 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.30767136 |
| 151 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30751737 |
| 152 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29884079 |
| 153 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28346278 |
| 154 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28128847 |

